2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates CancerNetwork® Inaugural Face-Off Contemporary Concepts in Hematologic Oncology Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer Real-World Evidence in NSCLC Guides Clinical Decisions Register: Recent Advances in the Treatment of Multiple Myeloma: Highlights from the IMS 2022 Meeting and Beyond Targeting NSCLC with Uncommon EGFR Mutations

2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer UpdatesCancerNetwork® Inaugural Face-OffContemporary Concepts in Hematologic OncologyInsights from Experts at Mayo Clinic on Translating Evidence to Clinical PracticeOptimizing Outcomes in Patients with HER2+ Metastatic Breast CancerReal-World Evidence in NSCLC Guides Clinical Decisions Register: Recent Advances in the Treatment of Multiple Myeloma: Highlights from the IMS 2022 Meeting and BeyondTargeting NSCLC with Uncommon EGFR Mutations

Clinical

View More Acute Myeloid Leukemia Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Acute Myeloid LeukemiaBrain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

Clinical Topics Integrative Care Global Bulletin All News Approval Alert

Clinical TopicsIntegrative CareGlobal BulletinAll NewsApproval Alert

Media

2 Minute Drill Around the Practice Between the Lines Clinical Consult Expert Interviews Face Off Medical World News OncView Podcasts Readout 360 Year in Review

2 Minute DrillAround the PracticeBetween the LinesClinical ConsultExpert InterviewsFace OffMedical World NewsOncViewPodcastsReadout 360Year in Review

Conferences

Publications

All Journals For Authors Tumor Board

All JournalsFor AuthorsTumor Board

Contemporary Concepts Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored

Contemporary ConceptsInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates
CancerNetwork® Inaugural Face-Off
Contemporary Concepts in Hematologic Oncology
Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice
Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer
Real-World Evidence in NSCLC Guides Clinical Decisions
Register: Recent Advances in the Treatment of Multiple Myeloma: Highlights from the IMS 2022 Meeting and Beyond
Targeting NSCLC with Uncommon EGFR Mutations

ClinicalSee All >

Acute Myeloid Leukemia
Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Newer Targeted Approaches in Medullary Thyroid Cancer

June 6, 2018

Manisha Shah, MD

Conference | American Society of Clinical Oncology Annual Meeting (ASCO)

In this video, Dr. Manisha Shah highlights new and emerging targeted therapies for medullary thyroid cancer, including research presented at ASCO 2018.

In this video, Dr. Manisha Shah highlights new and emerging targeted therapies for medullary thyroid cancer, including research presented at ASCO 2018.

Howard A. Burris, MD, Talks QOL With Durvalumab/Chemo in Advanced Biliary Tract Cancer From TOPAZ-1 Trial

Larotrectinib Trial Yields Promising Real-World Findings in TRK Fusion–Positive Disease

Shubham Pant, MD, Highlights the Potential of ELI-002 2P to Treat MRD in KRAS-Mutant Solid Malignancies